Cargando…
A case of small-cell lung cancer with adrenocorticotropic hormone deficiency induced by nivolumab
Anti-programmed death-1 (anti-PD-1) monoclonal antibodies, such as nivolumab, have been used for the treatment of various types of cancers, and excellent efficacy has been shown in some patients. The adverse effects of anti-PD-1 antibodies relating to autoimmunity are different from traditional chem...
Autores principales: | Zhu, Yan, Wu, Hong Hua, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438139/ https://www.ncbi.nlm.nih.gov/pubmed/30988622 http://dx.doi.org/10.2147/OTT.S194094 |
Ejemplares similares
-
A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency
por: Sato, Yozo, et al.
Publicado: (2019) -
Isolated Adrenocorticotropic Hormone Deficiency Caused by Nivolumab in a Patient with Metastatic Lung Cancer
por: Takaya, Kazuhiko, et al.
Publicado: (2017) -
Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report
por: Simeni Njonnou, Sylvain Raoul, et al.
Publicado: (2022) -
Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report
por: Takeno, Ayumu, et al.
Publicado: (2019) -
Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature
por: Ohara, Nobumasa, et al.
Publicado: (2019)